• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Par Drugs and Chemicals Limited — Board Meeting, 10-02-2026: Outcome of Board Meeting

    10-02-2026 | 05:28 pm

    PAR Drugs & Chemicals board approved Q3 & 9-month standalone financial results. Q3 revenue reached ₹30.67 Cr, with profit at ₹4.80 Cr & EPS of ₹3.90. The 9-month profit hit ₹12.25 Cr. Board also affirmed its independent directors and updated the related-party transaction policy.

    No comments yet. Be the first to comment!

    All announcements from Par Drugs and Chemicals Limited